Patent Grant
11694794
Many portable devices include a touchscreen on which symbols are displayed and from which inputs are received for operation of the portable device. A series of screens or windows can displayed on the touchscreen, showing alphanumeric text and symbols and providing menu screens through which the user can control operation of the portable device. User interaction, such as by touching the alphanumeric text and symbols, provides user input and facilitates navigation through the menu screens and selection of the device functions. Under some conditions, it is desirable to ignore user interaction with the touchscreen. For example, when the portable device is placed in a pocket or a purse, physical contact from objects in the pocket or purse may cause inadvertent device operation to occur. In such conditions, the touchscreen may be placed in a lock condition. The user is then required to perform a particular interaction to resume acceptance of device input through the touchscreen.
One example of a portable device such as described above is a device that involves the delivery of fluids. There are many applications in academic, industrial, and medical fields, as well as others, that involve devices that are capable of accurately and controllably delivering fluids, including liquids and gases, that have a beneficial effect when administered in known and controlled quantities. This is particularly true in the medical field where treatments for many patients include the administration of a known amount of a substance at predetermined intervals. The treatment of diabetes involves just such a regimented dosage of medicament such as insulin. In addition, the administration of insulin for a diabetic patient is one of a few medical indications in which the patient routinely administers the medicament to themselves by a subcutaneous modality, such as a hypodermic syringe injection. As such, providing a patient with the means to safely, reliably, and comfortably administer required doses of medication is particularly important in order to facilitate patient compliance and accurate treatment of the condition.
Insulin infusion pumps have been developed for the administration of insulin for those diagnosed with both type I and type II diabetes. Insulin pumps are medical infusion devices used for the administration of insulin in the treatment of diabetes that offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. They also allow for continuous insulin therapy.
The functions performed by infusion pumps and similar devices make it especially important to avoid inadvertent device operation. For example, infusion pumps may be programmed to initiate delivery of fluids at different times of a day, but such delivery would be annoying or even dangerous if a user happens to be involved in replacing a cartridge or changing a tube at the time of the programmed delivery time. Such load sequences of operation should not be interrupted until completion. Relatively simple display lock protections may not be adequate to protect against programmed device operation when a user is engaging in an activity that should not be interrupted.
Accordingly, there is a need for a portable medical device that safely facilitates user interaction while in a particular mode in which device activation could be problematic.
Inadvertent activation of a portable medical device such as an ambulatory infusion pump can be reduced by locking a touchscreen of the device when it is indicated that an uninterrupted operation is to be performed. When a processor receives a device operation input from the touchscreen that indicates an uninterrupted operation is to be performed on the portable device, the touchscreen is automatically locked such that touch input at the touchscreen is not processed by the processor to navigate between or among menu screens or set pump parameters. Following completion of the uninterrupted operation, the touchscreen can be unlocked. In one embodiment, the touchscreen can be unlocked by selection of an unlock icon on the touchscreen.
In an embodiment, an ambulatory infusion pump includes a housing, a delivery mechanism adapted to facilitated delivery of fluid to a user and a user interface comprising a touchscreen. A processor can be configured to generate menu screens for display on the touchscreen and to receive and process touch input from the touchscreen for navigation between or among the menu screens and for setting pump parameters. The processor can further be configured to receive touch input through the user interface that indicates an uninterrupted operation is to be performed on the pump. In response to this touch input, the processor can automatically locked the touch screen to prevent navigation between or among the menu screens or setting of pump parameters. Following completion of the uninterrupted operation, the touchscreen can be unlocked.
In some embodiments, inadvertent activation is reduced by generating a plurality of menu screens for display on a touchscreen of the portable device. The processor can receive a device operation input from the touchscreen that indicates an uninterrupted operation is to be performed on the portable device. The processor responds by setting a state of the portable device that is associated with the device operation input, maintaining the set state until at least a first predetermined touch input and a second predetermined touch input that are separated in time and each associated with a different corresponding first and second predetermined menu screen are received at the processor from the touchscreen. The processor only permits navigation from the first predetermined menu screen to the second predetermined menu screen in response to the first predetermined touch input, and the processor responds to the second predetermined touch input by changing the state of the portable device. Limiting the user interaction in this way can increase the device safety by permitting user interaction only in the sequence from the first predetermined menu screen to the second predetermined menu screen for a particular operating mode.
In an embodiment, a portable device includes a housing, a touchscreen having a surface on which a plurality of menu screens are displayed and from which touch input is received, and a processor in the housing configured to generate menu screens for display on the touchscreen and to receive the touch input from the touchscreen for navigation among the menu screens. The processor responds to receipt of a device operation input that indicates an uninterrupted operation is to be performed on the device by setting a state of the portable device that is associated with the device operation input and maintaining the set state until at least a first predetermined touch input and a second predetermined touch input that are separated in time and each associated with a different corresponding first and second predetermined menu screen, are received from the touchscreen. The processor only permits navigation from the first predetermined menu screen to the second predetermined menu screen in response to the first predetermined touch input, and the processor responds to the second predetermined touch input by changing the state of the portable device.
Other features and advantages of the present invention should be apparent from the following description of preferred embodiments that illustrate, by way of example, the principles of the invention.
The drawings illustrate embodiments of the technology and are not limiting. For clarity and ease of illustration, the drawings may not be made to scale and, in some instances, various aspects may be shown exaggerated or enlarged to facilitate an understanding of particular embodiments.
Disclosed herein are embodiments directed to a portable medical device having an interactive, e.g., touch, display screen that automatically locks when the system is in a load sequence which changes the physical state of the device.
Referring to
The portable device 100 can include an infusion cartridge 102 having an infusion set connector 104 for connection to a patient 105, and optionally a glucose meter (not illustrated). The infusion cartridge 102 can be functionally and interchangeably inserted into a receiving slot 106 in a housing 108 of the portable infusion pump device 100. The portable device includes a touchscreen 110 on which alphanumeric text, symbols, menu screens, data, and the like can be displayed, and from which user input may be received via interaction such as by pressing the outer surface of the touchscreen. The type of output/display may vary as may be useful for particular application, such as LCD displays, LED displays, plasma displays, OLEO displays, organic LED (OLED) displays, and the like. The touchscreen 110 may be implemented with a capacitance screen, a resistive screen, or other such display/input technology. The portable device 100 may additionally include a keyboard or other input device known in the art for data entry, which may be separate from the display. The device may also include a capability to operatively couple via a wired or wireless (e.g., infrared, electronic, optical, etc.) link to one or more other devices, locally or via a network, such as, e.g., a portable or non-portable medical device, a control unit, external monitor or display, a personal laptop, tablet or mainframe computer, or mobile communication device such as a smartphone or personal digital assistant (PDA), or the like. Such other devices may control or be controlled by device 100 and/or may otherwise communicate for the transfer of data between or among device 100 and other device(s) for analysis of data (e.g., user data for physician review, device diagnostic data for troubleshooting or repair), programming, or other uses.
The infusion cartridge 102 can have an outlet 112 that is coupled to an infusion tube 114 and the infusion set connector 104. The tube 114 and connector 104 comprise an infusion circuit that delivers medicament to the patient 105 at programmed times and in response to manually initiated delivery.
The housing 108 of the infusion pump device 100 can be configured to have any suitable shape and size. For instance, the housing 108 may be substantially planar, or may be extended and tubular, or may be in the shape of a square, rectangle, circle, ellipse cylinder or the like. The housing 108 can be dimensioned so as to be comfortably associated with a user and/or hidden from view, for instance, placed within the clothing of a user or within a case or sleeve. For some embodiments, the housing of the pump device can have a width of about 2.5 inches to about 3.5 inches, a height of about 1.0 inch to about 2.0 inches and a thickness of about 0.2 inches to about 0.6 inches. The materials of the housing 108 can vary as well. In some embodiments, the housing may be constructed as a water-tight, or water-resistant plastic, metallic or composite housing that is glued or otherwise fastened together permanently or semi-permanently.
A unique complication can occur for diabetic users in that they often build up calluses on the tips of their fingers as a result of blood glucose testing, which may be problematic for operation of capacitive-based touch screen configurations. For example, calluses may prevent or hinder the transfer of energy that the capacitive screens use to receive input. Accordingly, in certain embodiments, the touchscreen may be a resistive-based touchscreen. The touchscreen, or touch-sensitive display, may be configured to display menu screens or pages that allow the user to input data fields, e.g., select variable inputs, so as to allow the program to produce a suggested delivery amount, rate, profile, and/or the like in an intuitive, manipulatable and/or graphic representation. The user can therefore interact with the screen to shape the characteristic/form of the delivery amount, rate, and/or graphic delivery profile, e.g., by manipulating the delivery estimate or pattern displayed on the screen to effectuate the actual delivery. The portable infusion device may additionally include a keyboard or other device known in the art for data entry. Such data entry may be separate from the screen and/or display.
Information provided by the portable infusion device may be presented on the display screen as any number of objects, including one or more numeric and/or alphanumeric values, a range, a value or range that is presented in the form of a drop-down menu, a toggle that can be adjusted by the user, a graphical representation (e.g., icon) or an animated graphic, for example. In certain embodiments, the value is a range of values that are presented on a screen of the display as a toggle, wherein the toggle may be adjusted upwards or downwards by the user wiping a finger over the screen to select the appropriate value range, e.g. appropriate range of amounts of medicament such as insulin to be delivered and/or the appropriate rate, time, or interval of medicament delivery. In certain instances, the values presented in the range may be adjusted by the processor (illustrated in
An infusion workflow, or protocol, may be at least part of a program that is executed by the processor to display a sequence of menu pages to assist a user to at least program or control the portable infusion device and/or at least one operation comprising input, change, confirm, or view various information within the device. Any part of a workflow or protocol may include any number of queries for prompting the user to enter, modify, or confirm information can be presented to the user on the touchscreen display.
For example, a program accessible by the processer that includes an infusion workflow or protocol may enable a user to program the portable infusion device to deliver insulin to the user. In addition, an infusion workflow may present the user with a number of understandable queries enabling the user to enter, confirm, or modify information regarding the physiological conditions of the user. For instance, the menu pages may present a series of queries to a user during the execution of a program and may enable a user to set various settings within the portable infusion device (e.g., the time, date, or one or more alarms) and/or enter information about the user's present or predicted conditions (e.g., blood glucose level, physiological conditions, food to be ingested, and the like). In general, the sequence of menu pages may comprise a linear flow in that each menu page provides an icon or symbol that initiates a next step or menu page in the workflow and also provides an icon or symbol that reverses the workflow to proceed to a preceding menu page in the workflow.
In some embodiments, the user is provided with a virtual form displayed on the touch screen display for the user to complete. A virtual form enables a user to directly select and manipulate one or more parts of a displayed virtual form, with each part generally representing a setting. In this way, a user is not required to navigate through a generally linear workflow or protocol and/or prompted with a series of queries. Instead, the user is presented with a single page where the user completes the virtual form in order to initiate a programmed delivery of insulin, as will be discussed in greater detail below and shown by way of example in
Some menu page or screen representation embodiments of the menu page workflow enable a user to easily access and view one or more settings and information within the portable infusion device. A single page may include one or more objects simultaneously presented on the touch screen, where an object may be any number of text, numbers, graphs, pictures, video, or combination thereof which display information to a user.
The settings and information may have been entered by a user and/or presented by the portable infusion device, and may be one of information regarding the amount of insulin already present in the body, e.g., insulin on board; blood glucose level; trending glucose level; insulin sensitivity/insensitivity; glycemic index; metabolism; metabolic rate; stress level; physiological conditions, e.g., age, health, sickness, diurnal cycles, etc; measurable parameters: hormones, steroids, etc.; pharmacokinetics of the medicament, e.g., age of insulin, decay rate, etc.; food to be ingested, e.g., carbohydrates, proteins, fat; activity; use history; calendared events; environment, e.g., temperature, humidity, pressure, etc.; and the like. An object may represent any information without departing from the scope herein, and may also be in the form of a pictogram to generally intuitively represent a program, file, user, setting, status, profile, action, combination of the foregoing, or other entity or combination of entities discussed herein.
Referring now to
A control processor 23 is connected to the system bus 22 and receives the data communications from the connector data element 20 for processing. The control processor 23 controls operation of the various elements of the portable device 100 that are connected to the system bus 22. The control processor operates according to program instructions that may be stored in the device memory 24. Program instructions may also be stored in processor memory of the control processor 23. The control processor also stores data from its operations in the memory 24. The control processor controls a data communications element 25 that may comprise a receiver/transmitter for wireless RF communications, such as “WiFi” communications or “Bluetooth” communications between the portable medical device 10 and compatible external systems and networks. The portable infusion device may include an interface that allows a user such as a patient to interact with the programming of the processor to determine an amount of fluid to be delivered, a rate of delivery, a delivery profile, and/or the like.
As shown in
Accordingly, the processor may include programming that it can execute to control the speed of translation of a pump mechanism, the release of fluid from the reservoir, the data to be displayed by a display, the data to be transmitted via the transmitter, the one or more alarms, etc. The processor may also include programming that allows the processor to receive signals and/or other data from an input device, receiver, various sensors (such as a sensor that may be included as a part of the device or used in conjunction therewith, for instance, a blood glucose monitor and/or a blood glucose sensor, and the like) and to store the same in a memory. The memory can be any type of memory capable of storing data and communicating that data to one or more other components of the device, such as the processor.
The memory 24 of the device 100 may be any type of memory capable of storing data and retrieving that data for transfer to one or more other components of the device, such as the control processor 23. The memory 24 may comprise one or more of a flash memory, SRAM, ROM, DRAM, RAM, EPROM, dynamic storage, and the like. For the illustrated portable medical device 100 embodiment of
The device 100 can comprise an insulin pump device, which therefore also includes a drive/pump element 27 such as a pumping mechanism for delivery of insulin fluid to the connecting tube 14, as described above in connection with
The actuator or drive mechanism may be configured for actuating or otherwise effecting the translation of a pump piston or element such as a spool or shuttlecock. The actuator may be any mechanism that is capable of causing the translation of the spool. For instance, the actuator may include an electric coil, a ferrite member, a nitinol member, a lever arm, corresponding magnets or electric magnets or dipoles.
As indicated above, the egress may be configured so as to communicate with the spool translation chamber and/or spool and/or one or more openings therein. The egress may further be configured for opening and closing or otherwise regulating the amount of fluid that is allowed to pass there through. In this manner, the reservoir interacts with the delivery mechanism to effectuate the delivery of a stored fluid from the reservoir, through the delivery mechanism, and out of the portable infusion device, e.g., via an infusion set.
Referring now to
The user defined profile can allow the user to set alerts (e.g., site reminders), delivery amounts, temperature delivery rates, test times, and the like. The user-defined profile can also allow the user to change the physical state of the device, such as when a cartridge requires replacement, or when a tubing or cannula require filling. Modifying the physical state of the device, also affects the active physical state of the portable medical device, as described in the load sequence of
As shown in
As shown in
If no letter “B” 401 appears on the home screen, then the portable medical device is in an inactive state, and no basal or bolus deliveries are occurring. Such a state is shown in FIG. and will be described further with reference to
Referring to
In step 309, if the Site Reminder is “Off”, the device then checks to determine if a cartridge is installed/detected within the device. If a cartridge is not detected, the portable medical device provides the user with only two options in the load menu 311: 1) enter the change cartridge load sequence, or 2) enter the site reminder edit sequence (to turn on and program the Site Reminder function).
Referring to
Referring to step 307, if the site reminder is set to “On”, the user is shown a load menu 315 in which all load sequence options are available for selection by the user and the Site Reminder button indicates an “On” state. From the load menu 315, the user can select any option previously described along with the option to change the Site Reminder. If the user selects to change the Site Reminder as shown in step 345, the device then enters a workflow sequence “15-2”, show in box 347, to setup the site reminder from the load workflow. The set up of the Site Reminder from the load menu is slightly different than from the Fill Cannula workflow sequence. If the Site Reminder is set up through the load menu 315 as shown in step 345, the user is able to press a “Back” button to return to the load menu 315 at any time. However, if the user modifies the Site Reminder from the Fill Cannula workflow sequence, the “Back” button is inactive as the user cannot return to a previous state in the Fill Cannula workflow sequence until the sequence is completed. Accordingly, the Site Reminder is editable through the load menu and/or through the Fill Cannula sequence, though slight variations occur within the sequence which is followed for each setup.
Referring to load menus shown in boxes 311 (sequence 317 only), 313, and 315, the user can select a button to enter a load sequence, such as one of the buttons comprising Change Cartridge 317, Fill Tubing 319, or Fill Cannula 321. Each of the load sequence options is illustrated in
Furthermore, the Site Reminder 604 option is available for set-up due to its current “Off” state 607. Once at least one load sequence option has been selected and completed, the user can be provided with the option to complete the session in the menu by selecting the “Done” button 608 on the interactive touchscreen.
In step 323, if the user selects any one of the aforementioned load sequences, the processor of the device checks the pumping mechanism in order to determine if it is in an active pumping state. If the pump is not in an active state when a load sequence is selected, the user is sent to a corresponding workflow alert state. For example, if the user chose to load a cartridge, and the device is not in an active pumping state, the user is sent to a change cartridge alerts workflow, as shown in box 338. Similarly, if the device is in an inactive state and the user chose to enter a fill tubing workflow or a fill cannula workflow, the user is directed to each respective workflow as shown in boxes 340 and 342, respectively. If the pump is in an active state, the active physical state of the portable medical device should be stopped. Accordingly, the user is directed to a screen, which requires a user input to confirm that the active operation; e.g., pumping, of the portable medical device will be stopped. The user is then asked to enter “Yes” or “No” inputs for each of the load sequences to begin as shown in boxes 327, 329 and 331. This is provided in order for the user to avoid unwanted stopping of the pump, such as when a current scheduled infusion is occurring.
Referring to
Referring now to
If the Site Reminder is in the “On” state, then as shown in box 359, when all load sequences have been requested and completed by the user, the user can still be directed to the Load menu in order to configure and/or change the Site Reminder to the “On” state, since the portable medical device is then prepared for an active physical state. If the user has completed all load sequences and the Site Reminder is in the “On” state, the user can be provided with an option to enter an input of “Done” for the current workflow session. In some embodiments, if all load sequences, in particular the Fill Cannula load sequence, is complete, the Fill Cannula button is not active, or highlighted, for selection by the user though the completed checkmark is visible (e.g., highlighted or lit). This prevents the user from requesting an overflow of the cannula.
Referring again to boxes 357 and 359, once the user has entered and completed a particular load sequence, the user can be provided with, e.g., three (3) options to navigate away from the current device state. For example, in order for the user to exit the Load Menu and end a current workflow session, the user can select the “Done” button on the touchscreen of the device as provided in box 363. The Done button can take the user back to the Home Screen of the device, such as shown in
Referring to the Load menus 357, 359, 361, in a second option to navigate away from any of these screens, the user can select the “Back” button. The Back button takes the user out of the current workflow session, or a specific workflow sequence in which the device currently is, to the Options menu. Prior to displaying the Options menu to the user, the system can run a similar check state of 369 discussed in the previous paragraph, which navigates to the notification screen of “Test BG in 1-2 hours” in box 371 if at least one load sequence has been completed and then to the resume active state 373. Again, the device bypasses the notification in box 371 if no load sequence has been completed by the device, and automatically enters the resume active state workflow in box 373. Once in the active state and not in the locked state, such as when the device is capable of being unlocked, the user is free to navigate through the device to perform tasks such as selecting custom options, editing and generating profiles, and viewing stored data.
Referring now to
As shown in
If the device is not recovering from a fault state, the processor then runs a second check to determine if the date provided on the device is valid, as provided in state 379. If the check fails; e.g., the date is incorrect, the user can receive an error message indicating the problem in box 379a. The user is then asked to confirm receipt of the error message by selecting a “Close” button as provided in box 384. The user is then directed to the Options menu for “Resume Insulin state” provided in box 385 in order to troubleshoot the current detected error. All active operation of the device; e.g., pumping, remains in the “Off” state and no deliveries are occurring.
If the device has a valid date, the processor then runs a third check to determine if the mechanical components, such as the buttons on the touchscreen or other push buttons on the device, are malfunctioning as provided in state 380. If a button is malfunctioning, such as by being stuck, the user is again notified via an error message in 380a that the device will not resume an active pumping state. The user is then asked to confirm receipt of the error message by selecting a “Close” button as provided in state 384. The user is then directed to the Options menu for “Resume Insulin state” provided in box 385 in order to troubleshoot the current detected error. All active operation of the device; e.g., pumping, remains in the “Off” state and no deliveries are occurring.
Referring to
If the portable medical device has sufficient battery power to operate in an active state, the processor performs the next check to determine if any outside factors may affect the correct operation of the device. As shown in state 382, the fourth check is utilized to determine if the processor detects any extreme temperatures. Extreme temperatures may be the result of outside conditions, such as extremely hot or cold outside temperatures. In the case of an extremely hot temperature, the user is again provided with an error message indicating that the device detects a high temperature provided in box 382a, and the user is then asked to confirm receipt of the error message by selecting a “Close” button as provided in box 384. The user is then directed to the Options menu for “Resume Insulin state” provided in box 385 in order to troubleshoot the current detected error. All active operation of the device, e.g., pumping, remains in the “Off” state and no medicament delivery is occurring. In some embodiments, a similar operation is provided in the case of an extremely cold temperature.
Finally, the processor of the portable medical device performs a fifth check to again determine if an additional outside factor of altitude is detected in state 383. If an abnormal altitude is detected, the device may not operate properly. Accordingly, if a high altitude is detected, then the user is provided a notification of high altitude being detected such that an active state cannot be resumed in box 383a. The user is then asked to confirm receipt of the error message by selecting a “Close” button as provided in box 384.
If the processor of the device detects a suitable altitude for operation, the Load Menu Complete workflow sequence then performs individual checks of the physical components of the device that provide proper active operation in states 386, 387 and 388. The processor of the portable medical device first determines if the Cartridge Tubing has been filled in state 386. If the tubing is not filled, the user is provided a sequence of screens similar to the aforementioned checks. First, the user is notified in an error message in box 386a that the Cartridge Tubing must be filled to continue with active operation of the portable medical device. The user is then asked to confirm receipt of the error message by selecting a “Close” button as provided in box 389. The user is then directed to the Options menu for “Resume Insulin state” provided in box 390 in order to troubleshoot the current detected error. All active operation of the device, e.g., pumping, remains in the “Off” state and no deliveries are occurring.
Next, if the cartridge tubing is successfully filled as noted by the green check mark on the “Fill Tubing” bar 602, the processor of the device performs a check to determine if the cartridge has been successfully loaded into the device in state 387a. If the cartridge was installed incorrectly, the user is notified in an error message that the cartridge requires reinstallation. The user is then asked to confirm receipt of the error message by selecting a “Close” button as provided in box 389. The user is then directed to the Options menu for “Resume Insulin state” provided in box 390 in order to troubleshoot the current detected error. All active operation of the device; e.g., pumping, remains in the “Off” state and no deliveries are occurring.
Referring to
Referring to
In the previously described Load Menu Complete workflow sequence, it should be understood that all or some of the checks performed on the device can be sequentially or simultaneously performed. Additionally, at any step within the Load Menu Complete workflow sequence, similar to any step navigating through the device from the Home screen to the Option Menu and, subsequently, to the Load Menu, the user is provided with at least two options to navigate away from current screen by selecting a “Yes”, “No”, “Continue”, “Back” or “Close” button. The “Close” button allows the device to remain in a hold state in order for a notification message to be confirmed by the user. However, after acceptance, e.g., interaction with the screen on the “Close” button, the user is directed to a following screen which offers two or more options for the user to navigate through functions of the device; e.g., the load sequence options on the Load menu.
Referring now to
As shown in
Referring again to
In particular, the Change Cartridge load sequence, along with the Fill Tubing and Fill Cannula load sequences, includes a failsafe mechanism that locks the screen of the device during a physical modification (e.g., removal/installation of cartridge, filling of cannula, etc.) such that any inadvertent interaction with the screen of the device is avoided. Accordingly, though the device is still functional; e.g., background processing is occurring, the current state of the device cannot be modified until the screen is unlocked. For example, if the user touches the screen of the device while removing the cartridge or filling the tubing, the screen will not input the touch that causes the device 1301 to move away from the current screen in the workflow process and begin, for example, the delivery of the insulin to the tube when disconnected from the patient on accident.
As provided in
Referring again to
If the user enters “Next” in box 132 of
Referring still to
Referring to
Referring now to
Referring again to
Once the user completes the load sequence step of filling the cartridge and selecting the “Unlock” button, the processor only allows the user to navigate to the next confirmation screen with selection of the unlock button after a physical state change has occurred on the device. The confirmation screen provided in box 180 is similar to those previously described in boxes 132 and 148 of
As previously described with reference to boxes 132 and 148 of
In further embodiments, the user can enter the Fill Tubing workflow, or Load Sequence from the Load Menu. Further details of such operations will be apparent to those skilled in the art, in view of the description in this document.
Although the aforementioned description specifically describes a portable medical device for administering insulin to a patient, it should be understood that such a device is only one embodiment of the invention. The device can also include any portable device having a display and a processor and which is capable of remaining in a specific response state while the another operation is being performed on the device. For example, the device can include a mobile computing device, such as a Smartphone. In one embodiment, such a device can be used to remotely control a portable medical device as described herein. Alternatively, a portable medical device as described herein may be controlled by a dedicated remote control specifically designed for use with the device. The response state can be preventing any user input while a user is downloading an application through a wireless connection, or completing a bank transaction, for example.
The methods, systems, and devices discussed above are intended merely to be examples. Various embodiments may omit, substitute, or add various procedures or components as appropriate. For example, it should be appreciated that, in alternative embodiments, the methods may be performed in an order different from that described, and various steps may be added, omitted, or combined. Also, features described with respect to certain embodiments may be combined in various other embodiments. Different aspects and elements of the embodiments may be combined in a similar manner. Also, it should be emphasized that technology evolves and, thus, many of the elements are examples and should not be interpreted to limit the scope of the invention.
Specific details are given in this description to provide a thorough understanding of the embodiments. Nevertheless, it will be understood by one of ordinary skill in the art that the embodiments may be practiced without these specific details. For example, well-known circuits, processes, algorithms, structures, and techniques have been shown without unnecessary detail in order to avoid obscuring the embodiments. Further, the headings provided herein are intended merely to aid in the clarity of the descriptions of various embodiments, and should not be construed as limiting the scope of the invention or the functionality of any part of the invention. For example, certain methods or components may be implemented as part of other methods or components, even though they are described under different headings.
It is noted that embodiments may have been described as a process that is depicted as a flow diagram or block diagram. Although each diagram may describe the process as a sequential series of operations, many of the operations can be performed in parallel or concurrently. In addition, the order of the operations may be rearranged. A process may have additional steps not included in the figures. Each operation of a process is performed or executed by the processor of the device.
The description above has been provided in terms of presently preferred embodiments so that an understanding of the present invention can be conveyed. There are, however, many configurations and techniques for data management systems that were not specifically described herein, but with which the present invention is applicable. The present invention should therefore not be seen as limited to the particular embodiments described herein, but rather, it should be understood that the present invention has wide applicability with respect to data management generally. All modifications, variations, or equivalent arrangements and implementations that are within the scope of the attached claims should therefore be considered within the scope of the invention.
This application is a continuation of application Ser. No. 13/801,274 filed Mar. 13, 2013, which claims the benefit of U.S. Provisional Application No. 61/637,210 filed Apr. 23, 2012, each of which is fully incorporated herein in its entirety by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4810243 | Howson | Mar 1989 | A |
| 5247434 | Peterson et al. | Sep 1993 | A |
| 5338157 | Blomquist | Aug 1994 | A |
| 5485408 | Blomquist | Jan 1996 | A |
| 5497772 | Schulman et al. | Mar 1996 | A |
| 5498421 | Grinstaff et al. | Mar 1996 | A |
| 5558638 | Evers et al. | Sep 1996 | A |
| 5639473 | Grinstaff et al. | Jun 1997 | A |
| 5660163 | Schulman et al. | Aug 1997 | A |
| 5681285 | Ford et al. | Oct 1997 | A |
| 5685844 | Marttila | Nov 1997 | A |
| 5707212 | Matthews | Jan 1998 | A |
| 5728396 | Peery et al. | Mar 1998 | A |
| 5782805 | Meinzer et al. | Jul 1998 | A |
| 5830195 | Peters et al. | Nov 1998 | A |
| 5848593 | Mcgrady et al. | Dec 1998 | A |
| 5935099 | Peterson et al. | Aug 1999 | A |
| 5964724 | Rivera et al. | Oct 1999 | A |
| 5985305 | Peery et al. | Nov 1999 | A |
| 5988851 | Gent | Nov 1999 | A |
| 6024539 | Blomquist | Feb 2000 | A |
| 6039251 | Holowko | Mar 2000 | A |
| 6056522 | Johnson | May 2000 | A |
| 6070761 | Bloom et al. | Jun 2000 | A |
| 6126642 | Kriesel et al. | Oct 2000 | A |
| 6198383 | Sekura et al. | Mar 2001 | B1 |
| 6241704 | Peterson et al. | Jun 2001 | B1 |
| 6269340 | Ford et al. | Jul 2001 | B1 |
| 6395292 | Peery et al. | May 2002 | B2 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6470234 | Mcgrady | Oct 2002 | B1 |
| 6475180 | Peterson et al. | Nov 2002 | B2 |
| 6493745 | Cherian | Dec 2002 | B1 |
| 6511435 | Bluth et al. | Jan 2003 | B1 |
| 6551276 | Mann et al. | Apr 2003 | B1 |
| 6554798 | Mann et al. | Apr 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6635014 | Starkweather et al. | Oct 2003 | B2 |
| 6635048 | Ullestad et al. | Oct 2003 | B1 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6687546 | Lebel et al. | Feb 2004 | B2 |
| 6694191 | Starkweather et al. | Feb 2004 | B2 |
| 6733446 | Lebel et al. | May 2004 | B2 |
| 6738052 | Manke et al. | May 2004 | B1 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6744350 | Blomquist | Jun 2004 | B2 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6788315 | Kekic | Sep 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman, IV et al. | Nov 2004 | B2 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6852104 | Blomquist | Feb 2005 | B2 |
| 6872200 | Mann et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6936029 | Mann et al. | Aug 2005 | B2 |
| 6950708 | Bowman, IV et al. | Sep 2005 | B2 |
| 6958705 | Lebel et al. | Oct 2005 | B2 |
| 6974437 | Lebel et al. | Dec 2005 | B2 |
| 6979326 | Mann et al. | Dec 2005 | B2 |
| 6990809 | Abouraphael | Jan 2006 | B2 |
| 6997920 | Mann et al. | Feb 2006 | B2 |
| 7024245 | Lebel et al. | Apr 2006 | B2 |
| 7025743 | Mann et al. | Apr 2006 | B2 |
| 7090648 | Sackner et al. | Aug 2006 | B2 |
| 7109878 | Mann et al. | Sep 2006 | B2 |
| 7118676 | Mueth et al. | Oct 2006 | B2 |
| 7141425 | Dzekunov et al. | Nov 2006 | B2 |
| 7171274 | Starkweather et al. | Jan 2007 | B2 |
| 7201730 | Davidner et al. | Apr 2007 | B2 |
| 7204823 | Estes et al. | Apr 2007 | B2 |
| 7207964 | Davidner et al. | Apr 2007 | B2 |
| 7256771 | Novak et al. | Aug 2007 | B2 |
| 7256888 | Staehr et al. | Aug 2007 | B2 |
| 7264730 | Connell et al. | Sep 2007 | B2 |
| 7303680 | Connell et al. | Dec 2007 | B2 |
| 7318892 | Connell et al. | Jan 2008 | B2 |
| 7347819 | Lebel et al. | Mar 2008 | B2 |
| 7347836 | Peterson et al. | Mar 2008 | B2 |
| 7351340 | Connell et al. | Apr 2008 | B2 |
| 7369635 | Spital et al. | May 2008 | B2 |
| 7390314 | Stutz, Jr. et al. | Jun 2008 | B2 |
| 7445616 | Petrakis | Nov 2008 | B2 |
| 7455663 | Bikovsky | Nov 2008 | B2 |
| 7471994 | Ford et al. | Dec 2008 | B2 |
| 7515060 | Blomquist | Apr 2009 | B2 |
| 7591801 | Brauker et al. | Sep 2009 | B2 |
| 7630791 | Nguyen et al. | Dec 2009 | B2 |
| 7651489 | Estes et al. | Jan 2010 | B2 |
| 7654976 | Peterson et al. | Feb 2010 | B2 |
| 7678071 | Lebel et al. | Mar 2010 | B2 |
| 7682338 | Griffin | Mar 2010 | B2 |
| 7699767 | Mueth et al. | Apr 2010 | B2 |
| 7713574 | Brister et al. | May 2010 | B2 |
| 7717903 | Estes et al. | May 2010 | B2 |
| 7736338 | Kavazov et al. | Jun 2010 | B2 |
| 7774145 | Brauker et al. | Aug 2010 | B2 |
| 7778680 | Goode, Jr. et al. | Aug 2010 | B2 |
| 7789857 | Moberg et al. | Sep 2010 | B2 |
| 7797028 | Goode, Jr. et al. | Sep 2010 | B2 |
| 7801596 | Fischell et al. | Sep 2010 | B2 |
| 7811279 | John | Oct 2010 | B2 |
| 7815602 | Mann et al. | Oct 2010 | B2 |
| 7819843 | Mann et al. | Oct 2010 | B2 |
| 7828528 | Estes et al. | Nov 2010 | B2 |
| 7831310 | Lebel et al. | Nov 2010 | B2 |
| 7837647 | Estes et al. | Nov 2010 | B2 |
| 7837651 | Bishop et al. | Nov 2010 | B2 |
| 7875022 | Wenger et al. | Jan 2011 | B2 |
| 7912674 | Killoren Clark et al. | Mar 2011 | B2 |
| 7914450 | Goode, Jr. et al. | Mar 2011 | B2 |
| 7925321 | Goode et al. | Apr 2011 | B2 |
| 7933639 | Goode et al. | Apr 2011 | B2 |
| 7933780 | De La Huerga | Apr 2011 | B2 |
| 7938792 | Roger et al. | May 2011 | B2 |
| 7955261 | Goode et al. | Jun 2011 | B2 |
| 7957984 | Vallone | Jun 2011 | B1 |
| 7959569 | Goode et al. | Jun 2011 | B2 |
| 7963954 | Kavazov | Jun 2011 | B2 |
| 7972296 | Braig et al. | Jul 2011 | B2 |
| 7976492 | Brauker et al. | Jul 2011 | B2 |
| 7976530 | Johnson et al. | Jul 2011 | B2 |
| 7976778 | Drucker et al. | Jul 2011 | B2 |
| 7979104 | Kamath et al. | Jul 2011 | B2 |
| 7986986 | Goode et al. | Jul 2011 | B2 |
| 7988674 | Adams et al. | Aug 2011 | B2 |
| 7988849 | Biewer et al. | Aug 2011 | B2 |
| 8002700 | Ferek-Petric et al. | Aug 2011 | B2 |
| 8012119 | Estes et al. | Sep 2011 | B2 |
| 8020564 | Batch | Sep 2011 | B2 |
| 8034019 | Nair et al. | Oct 2011 | B2 |
| 8034026 | Grant et al. | Oct 2011 | B2 |
| 8052601 | Goode, Jr. et al. | Nov 2011 | B2 |
| 8066197 | Sheppard | Nov 2011 | B2 |
| 8094009 | Allen et al. | Jan 2012 | B2 |
| 8109921 | Estes et al. | Feb 2012 | B2 |
| 8130095 | Allen et al. | Mar 2012 | B2 |
| 8147446 | Yodfat et al. | Apr 2012 | B2 |
| 8206350 | Mann et al. | Jun 2012 | B2 |
| 8211364 | Drucker et al. | Jul 2012 | B2 |
| 8221359 | Kristensen et al. | Jul 2012 | B2 |
| 8236242 | Drucker et al. | Aug 2012 | B2 |
| 8250483 | Blomquist | Aug 2012 | B2 |
| 8257652 | Drucker et al. | Sep 2012 | B2 |
| 8257653 | Drucker et al. | Sep 2012 | B2 |
| 8267921 | Yodfat et al. | Sep 2012 | B2 |
| 8290562 | Goode, Jr. et al. | Oct 2012 | B2 |
| 8310415 | Mclaughlin et al. | Nov 2012 | B2 |
| 8323188 | Tran | Dec 2012 | B2 |
| 8332008 | Goode et al. | Dec 2012 | B2 |
| 8344847 | Moberg et al. | Jan 2013 | B2 |
| 8346399 | Blomquist | Jan 2013 | B2 |
| 8369919 | Kamath et al. | Feb 2013 | B2 |
| 8390244 | Wooley et al. | Mar 2013 | B2 |
| 8395581 | Gråskov et al. | Mar 2013 | B2 |
| 8401194 | Nierzwick et al. | Mar 2013 | B2 |
| 8414563 | Kamen et al. | Apr 2013 | B2 |
| 8449523 | Brukalo | May 2013 | B2 |
| 8449524 | Braig et al. | May 2013 | B2 |
| 8451230 | Celentano et al. | May 2013 | B2 |
| 8460231 | Brauker et al. | Jun 2013 | B2 |
| 8504842 | Meacham | Aug 2013 | B1 |
| 8579853 | Reggiardo et al. | Nov 2013 | B2 |
| 8601465 | Bernstein | Dec 2013 | B2 |
| 8868794 | Masoud | Oct 2014 | B2 |
| 8893053 | Hyde et al. | Nov 2014 | B1 |
| 8929823 | Mears | Jan 2015 | B2 |
| 8932250 | Montgomery | Jan 2015 | B2 |
| 8963855 | Chen et al. | Feb 2015 | B2 |
| 8992475 | Mann | Mar 2015 | B2 |
| 9132227 | Bryant, Jr. | Sep 2015 | B2 |
| 9137301 | Dunlap | Sep 2015 | B1 |
| 9238100 | Kruse et al. | Jan 2016 | B2 |
| 9259531 | Kamen | Feb 2016 | B2 |
| 9335910 | Farnan et al. | May 2016 | B2 |
| 9715327 | Rosinko et al. | Jul 2017 | B2 |
| 11217339 | Blomquist | Jan 2022 | B2 |
| 20010031944 | Peterson | Oct 2001 | A1 |
| 20020029776 | Blomquist | Mar 2002 | A1 |
| 20020078393 | Parker | Jun 2002 | A1 |
| 20020143290 | Bui et al. | Oct 2002 | A1 |
| 20020183693 | Peterson et al. | Dec 2002 | A1 |
| 20030065308 | Lebel et al. | Apr 2003 | A1 |
| 20030163088 | Blomquist | Aug 2003 | A1 |
| 20030163223 | Blomquist | Aug 2003 | A1 |
| 20030163789 | Blomquist | Aug 2003 | A1 |
| 20030195974 | Ronning | Oct 2003 | A1 |
| 20030212364 | Mann et al. | Nov 2003 | A1 |
| 20040073095 | Causey et al. | Apr 2004 | A1 |
| 20040193090 | Lebel et al. | Sep 2004 | A1 |
| 20050022274 | Campbell et al. | Jan 2005 | A1 |
| 20050143864 | Blomquist | Jun 2005 | A1 |
| 20050160084 | Barrett | Jul 2005 | A1 |
| 20050171513 | Mann et al. | Aug 2005 | A1 |
| 20060173444 | Choy et al. | Aug 2006 | A1 |
| 20060229557 | Fathallah | Oct 2006 | A1 |
| 20070093786 | Goldsmith et al. | Apr 2007 | A1 |
| 20070118405 | Campbell et al. | May 2007 | A1 |
| 20070156033 | Causey et al. | Jul 2007 | A1 |
| 20070219480 | Kamen et al. | Sep 2007 | A1 |
| 20070219496 | Kamen et al. | Sep 2007 | A1 |
| 20070219597 | Kamen et al. | Sep 2007 | A1 |
| 20070228071 | Kamen et al. | Oct 2007 | A1 |
| 20070287985 | Estes et al. | Dec 2007 | A1 |
| 20080033357 | Mann et al. | Feb 2008 | A1 |
| 20080065007 | Peterson et al. | Mar 2008 | A1 |
| 20080065016 | Peterson et al. | Mar 2008 | A1 |
| 20080119705 | Patel et al. | May 2008 | A1 |
| 20080122595 | Yamamichi et al. | May 2008 | A1 |
| 20080147004 | Mann et al. | Jun 2008 | A1 |
| 20080147050 | Mann et al. | Jun 2008 | A1 |
| 20080171967 | Blomquist et al. | Jul 2008 | A1 |
| 20080172026 | Blomquist | Jul 2008 | A1 |
| 20080172027 | Blomquist | Jul 2008 | A1 |
| 20080172028 | Blomquist | Jul 2008 | A1 |
| 20080172029 | Blomquist | Jul 2008 | A1 |
| 20080172030 | Blomquist | Jul 2008 | A1 |
| 20080172031 | Blomquist | Jul 2008 | A1 |
| 20080287922 | Panduro | Nov 2008 | A1 |
| 20080312584 | Montgomery | Dec 2008 | A1 |
| 20080312585 | Brukalo | Dec 2008 | A1 |
| 20090005729 | Hendrixson | Jan 2009 | A1 |
| 20090018495 | Panduro | Jan 2009 | A1 |
| 20090037020 | Brown | Feb 2009 | A1 |
| 20090067989 | Estes et al. | Mar 2009 | A1 |
| 20090069745 | Estes et al. | Mar 2009 | A1 |
| 20090082728 | Bikovsky | Mar 2009 | A1 |
| 20090085768 | Patel et al. | Apr 2009 | A1 |
| 20090101549 | Kamen et al. | Apr 2009 | A1 |
| 20090107335 | Wilt et al. | Apr 2009 | A1 |
| 20090108016 | Brown et al. | Apr 2009 | A1 |
| 20090156990 | Wenger et al. | Jun 2009 | A1 |
| 20090192724 | Brauker et al. | Jul 2009 | A1 |
| 20090212966 | Panduro | Aug 2009 | A1 |
| 20090221890 | Saffer et al. | Sep 2009 | A1 |
| 20090254037 | Bryant, Jr. et al. | Oct 2009 | A1 |
| 20090270833 | Debelser et al. | Oct 2009 | A1 |
| 20100069890 | Gräskov et al. | Mar 2010 | A1 |
| 20100107103 | Wallaert et al. | Apr 2010 | A1 |
| 20100121169 | Petisce et al. | May 2010 | A1 |
| 20100145262 | Bengtsson et al. | Jun 2010 | A1 |
| 20100152674 | Kavazov et al. | Jun 2010 | A1 |
| 20100156633 | Buck, Jr. | Jun 2010 | A1 |
| 20100168543 | Kamath et al. | Jul 2010 | A1 |
| 20100179402 | Goode, Jr. et al. | Jul 2010 | A1 |
| 20100198183 | Lanigan et al. | Aug 2010 | A1 |
| 20100228186 | Estes et al. | Sep 2010 | A1 |
| 20100256047 | Sieh | Oct 2010 | A1 |
| 20100257490 | Lyon | Oct 2010 | A1 |
| 20100261987 | Kamath et al. | Oct 2010 | A1 |
| 20100272452 | Tsukijima | Oct 2010 | A1 |
| 20100292556 | Golden | Nov 2010 | A1 |
| 20100312082 | Batman et al. | Dec 2010 | A1 |
| 20100318578 | Treu | Dec 2010 | A1 |
| 20100331824 | Moberg et al. | Dec 2010 | A1 |
| 20110006876 | Moberg et al. | Jan 2011 | A1 |
| 20110006880 | Long | Jan 2011 | A1 |
| 20110009724 | Hill | Jan 2011 | A1 |
| 20110009725 | Hill | Jan 2011 | A1 |
| 20110009813 | Rankers | Jan 2011 | A1 |
| 20110030845 | Chong et al. | Feb 2011 | A1 |
| 20110040247 | Mandro | Feb 2011 | A1 |
| 20110047499 | Mandro et al. | Feb 2011 | A1 |
| 20110053121 | Heaton | Mar 2011 | A1 |
| 20110071465 | Wang et al. | Mar 2011 | A1 |
| 20110081889 | Gao | Apr 2011 | A1 |
| 20110082439 | Wenger et al. | Apr 2011 | A1 |
| 20110092894 | Mcgill et al. | Apr 2011 | A1 |
| 20110098637 | Hill | Apr 2011 | A1 |
| 20110098638 | Chawla et al. | Apr 2011 | A1 |
| 20110098674 | Vicente et al. | Apr 2011 | A1 |
| 20110105854 | Kiani et al. | May 2011 | A1 |
| 20110106318 | Ledford | May 2011 | A1 |
| 20110119087 | Drucker et al. | May 2011 | A1 |
| 20110125085 | Mcgill et al. | May 2011 | A1 |
| 20110125095 | Lebel et al. | May 2011 | A1 |
| 20110125530 | Drucker et al. | May 2011 | A1 |
| 20110126188 | Bernstein et al. | May 2011 | A1 |
| 20110133946 | Kopp et al. | Jun 2011 | A1 |
| 20110137239 | Debelser et al. | Jun 2011 | A1 |
| 20110144586 | Michaud | Jun 2011 | A1 |
| 20110152770 | DiPerna et al. | Jun 2011 | A1 |
| 20110178461 | Chong et al. | Jul 2011 | A1 |
| 20110184264 | Galasso et al. | Jul 2011 | A1 |
| 20110190614 | Brister et al. | Aug 2011 | A1 |
| 20110190694 | Lanier, Jr. et al. | Aug 2011 | A1 |
| 20110208123 | Gray et al. | Aug 2011 | A1 |
| 20110256024 | Cole et al. | Oct 2011 | A1 |
| 20110257895 | Brauker et al. | Oct 2011 | A1 |
| 20120030610 | DiPerna et al. | Feb 2012 | A1 |
| 20120041415 | Estes et al. | Feb 2012 | A1 |
| 20120084728 | Huang | Apr 2012 | A1 |
| 20120093311 | Nierzwick | Apr 2012 | A1 |
| 20120095315 | Tenbarge et al. | Apr 2012 | A1 |
| 20120095393 | Reinke | Apr 2012 | A1 |
| 20120109100 | Estes et al. | May 2012 | A1 |
| 20120130204 | Basta et al. | May 2012 | A1 |
| 20120185267 | Kamen | Jul 2012 | A1 |
| 20120232520 | Sloan et al. | Sep 2012 | A1 |
| 20120238851 | Kamen | Sep 2012 | A1 |
| 20120266251 | Birtwhistle | Oct 2012 | A1 |
| 20120307126 | Bhogal | Dec 2012 | A1 |
| 20130050106 | Chung et al. | Feb 2013 | A1 |
| 20130117696 | Robertson | May 2013 | A1 |
| 20130137415 | Takikawa | May 2013 | A1 |
| 20130171938 | Mears | Jul 2013 | A1 |
| 20130172710 | Mears et al. | Jul 2013 | A1 |
| 20130190094 | Ronen | Jul 2013 | A1 |
| 20130191770 | Bartz | Jul 2013 | A1 |
| 20130283196 | Farnan et al. | Oct 2013 | A1 |
| 20130332874 | Rosinko et al. | Dec 2013 | A1 |
| 20130345625 | Causey, III et al. | Dec 2013 | A1 |
| 20140012511 | Mensinger et al. | Jan 2014 | A1 |
| 20140054883 | Lanigan et al. | Feb 2014 | A1 |
| 20140180711 | Kamen et al. | Jun 2014 | A1 |
| 20140276531 | Walsh | Sep 2014 | A1 |
| 20140323961 | Blomquist et al. | Oct 2014 | A1 |
| 20150072613 | Swanson | Mar 2015 | A1 |
| 20150182694 | Rosinko | Jul 2015 | A1 |
| 20150182695 | Rosinko | Jul 2015 | A1 |
| 20150217044 | Blomquist | Aug 2015 | A1 |
| 20160121047 | Kruse et al. | May 2016 | A1 |
| 20160199571 | Rosinko et al. | Jul 2016 | A1 |
| 20160271325 | Farnan et al. | Sep 2016 | A1 |
| 20170300206 | Rosinko et al. | Oct 2017 | A1 |
| Number | Date | Country |
|---|---|---|
| 0985420 | Mar 2000 | EP |
| 1769812 | Apr 2007 | EP |
| 2079011 | Jul 2009 | EP |
| WO 9524229 | Sep 1995 | WO |
| WO 0018449 | Apr 2000 | WO |
| WO03008014 | Jan 2003 | WO |
| WO2008127694 | Oct 2008 | WO |
| WO2009032399 | Mar 2009 | WO |
| WO2009032400 | Mar 2009 | WO |
| WO2011005633 | Jan 2011 | WO |
| Entry |
|---|
| US 8,333,733 B2, 12/2012, Lanigan et al. (withdrawn) |
| Title: Introduction to Windows in DOC. Publisher: Imperial college london. Publication date: Feb. 28, 2011. URL: http://web.archive.org/web/20110228233235/https://www.doc.ic.ac.uk/csg-old/windows/intro.html. |
| Search Report for EP Application No. 13781696.3 dated Nov. 25, 2015. |
| Search Report and Written Opinion dated Jul. 29, 2013 for PCT Application No. PCT/US-2013/037616 filed Apr. 22, 2013, 10 pages. |
| Written Opinion dated Oct. 28, 2014 for PCT Application No. PCT/US-2013/037616 filed Apr. 22, 2013, 6 pages. |
| Application and File History for U.S. Appl. No. 13/801,230, filed Mar. 13, 2013, inventor Rosinko et al. |
| PCT Search Report dated Sep. 4, 2013 for PCT Application No. PCT/US-2013/0044329 filed Jun. 13, 2013, 13 pages. |
| Communication dated Jun. 6, 2017 for EP Application No. 13800236.5. (9 pages). |
| IPRP for International PCT Application No. PCT/US-2013/0044329 dated Dec. 9, 2014. |
| Exam Report for European Application No. 13781696.3 dated Jan. 3, 2017. |
| Application and File History for U.S. Appl. No. 13/801,274, filed Mar. 13, 2013, inventors Farnan et al. |
| Application and File History for U.S. Appl. No. 15/592,595, filed May 11, 2017, inventors Rosinko et al. |
| Search Report dated Jun. 24, 2019 for EP Application No. 18211743.2, 11 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20160271325 A1 | Sep 2016 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61637210 | Apr 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13801274 | Mar 2013 | US |
| Child | 15149559 | US |
